MICROPORT (00853) surged another 5% in late trading. As of press time, the stock was up 5.1% to HK$16.08 with a trading volume of HK$267 million. On the news front, MICROPORT announced the restructuring of its cardiac rhythm management business, with subsidiary MicroPort HeartTech planning to merge with CRM Cayman. Market participants noted that this merger aims to resolve the performance pressure related to "meeting listing standards" for the cardiac rhythm business. JP Morgan indicated that the successful completion of the transaction would help eliminate major uncertainty factors that have been persistently troubling the company. Additionally, the company previously introduced Shanghai Industrial, which has a state-owned enterprise background, as a strategic shareholder. Guotai Haitong Securities stated that Shanghai Industrial Capital, leveraging its state-owned background and industrial resources, is expected to assist the group's core business expansion and potential strategic acquisitions, pursue superior corporate governance standards, and provide support for the group's continuous innovation, high-quality development, and scale enhancement.